[go: up one dir, main page]

DE69329942D1 - Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen - Google Patents

Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen

Info

Publication number
DE69329942D1
DE69329942D1 DE69329942T DE69329942T DE69329942D1 DE 69329942 D1 DE69329942 D1 DE 69329942D1 DE 69329942 T DE69329942 T DE 69329942T DE 69329942 T DE69329942 T DE 69329942T DE 69329942 D1 DE69329942 D1 DE 69329942D1
Authority
DE
Germany
Prior art keywords
halophenylpiperazinyl
antidepressant
triazole
ions
propyl derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329942T
Other languages
English (en)
Other versions
DE69329942T2 (de
Inventor
Robert F Mayol
George M Luke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE69329942D1 publication Critical patent/DE69329942D1/de
Application granted granted Critical
Publication of DE69329942T2 publication Critical patent/DE69329942T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69329942T 1992-04-28 1993-04-26 Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen Expired - Fee Related DE69329942T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/875,044 US5256664A (en) 1992-04-28 1992-04-28 Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones

Publications (2)

Publication Number Publication Date
DE69329942D1 true DE69329942D1 (de) 2001-03-29
DE69329942T2 DE69329942T2 (de) 2001-08-16

Family

ID=25365103

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329942T Expired - Fee Related DE69329942T2 (de) 1992-04-28 1993-04-26 Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen

Country Status (10)

Country Link
US (1) US5256664A (de)
EP (1) EP0568437B1 (de)
JP (1) JPH0641095A (de)
AT (1) ATE199253T1 (de)
CA (1) CA2094890C (de)
DE (1) DE69329942T2 (de)
DK (1) DK0568437T3 (de)
ES (1) ES2154644T3 (de)
GR (1) GR3035809T3 (de)
PT (1) PT568437E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
WO2000061129A2 (en) * 1999-04-09 2000-10-19 Sepracor Inc. S-hydroxynefazodone
ATE330607T1 (de) 1999-04-09 2006-07-15 Sepracor Inc R-hydroxynefazodon
JP3850224B2 (ja) 2001-03-26 2006-11-29 株式会社ジェイテクト 研削加工方法及び数値制御研削盤
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2356450C (en) * 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders

Also Published As

Publication number Publication date
CA2094890C (en) 2000-04-11
JPH0641095A (ja) 1994-02-15
US5256664A (en) 1993-10-26
ES2154644T3 (es) 2001-04-16
EP0568437A1 (de) 1993-11-03
ATE199253T1 (de) 2001-03-15
GR3035809T3 (en) 2001-07-31
DK0568437T3 (da) 2001-04-30
EP0568437B1 (de) 2001-02-21
DE69329942T2 (de) 2001-08-16
CA2094890A1 (en) 1993-10-29
PT568437E (pt) 2001-06-29

Similar Documents

Publication Publication Date Title
DE69329942D1 (de) Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen
ATE180468T1 (de) Anthranilsäure derivate
ATE92478T1 (de) Substituierte pyrrol-, pyrazol- und triazolangiotensin ii-antagonisten.
CA2194503A1 (en) 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use
DE69817393D1 (de) Neue heterozyklische verbindungen
NO922147D0 (no) Heterocykliske derivater
EP0902007A4 (de) Chalcon-derivate und medikamente die diese enthalten
ATE103604T1 (de) Substituierte 5-((tetrazolyl)alkenyl>-imidazole.
PT992509E (pt) Novos derivados macrolidos
ATE186301T1 (de) An den positionen 2 und 9 substituierte 4h-pyrido-(1,2-a)pyrimidin-4-one
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
HUT53886A (en) Fungicide preparations containing propencarboxylic acid derivatives as agents and process for producing the agents
NZ275620A (en) 3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
EP0919233B8 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
SE9901237D0 (sv) Novel use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee